ClearOne Mails Definitive Proxy for $15M Unit Offering and 855K Advisor Shares
CLRO has more than doubled off its 52-week low of $2.71.
Summary
ClearOne's majority stockholder approved a $15M unit offering at $3.50 per unit and 855,000 advisor shares. The unit offering alone could increase shares outstanding by roughly 61.6% before warrant exercises.
Key Events · Financing and Capital Events · CLRO
-
$15M Unit Offering Approved
Majority stockholder First Finance Ltd. approved issuance of units at $3.50 each — one share plus one warrant — for up to $15 million in gross proceeds.
-
Illustrative Dilution: 61.6%
At $3.50 per unit and full $15M raise, approximately 4,285,714 shares would be issued against 2,675,412 outstanding — a 61.6% increase before any warrant exercises.
-
855K Advisor Shares Approved
Four advisors receive shares: First Finance 25,000, Betelgeuse 90,000, Gang3 140,000, and JJK 600,000. Gang3 is controlled by director Eric Boehnke.
-
20-Day Clock Starts
The definitive information statement was mailed August 28, 2026; under Rule 14c-2 the issuances cannot close until at least 20 calendar days later.
Analysis · CLRO · Manufacturing
ClearOne's majority stockholder, First Finance Ltd., has approved two dilutive issuances by written consent: a $15 million unit offering at $3.50 per unit and 855,000 shares to four advisors. The unit offering alone could add approximately 4.29 million shares — a 61.6% increase over the 2.68 million shares currently outstanding — before any warrant exercises. The advisor shares include 140,000 to Gang3 Capital, which is controlled by director Eric Boehnke, creating a related-party element. This definitive filing starts the 20-day clock under Rule 14c-2, after which the issuances can close. The company is raising capital at a price well below its $6.00 current market price while simultaneously pursuing a reverse merger with Cortigent, suggesting urgent cash needs.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 36.1% of the 1753 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLRO was trading at $6.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $16M. The 52-week trading range was $2.71 to $16.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.